XBI
ETF
Biotechnology
NYSEARCA
SPDR S&P Biotech ETF
$137.68
+3.89 (+2.91%)
Fund Overview
by SPDR (State Street)
Equal-weighted biotech ETF. Gives small-cap clinical-stage biotech companies equal weight with large-cap pharma-like biotechs, creating a higher risk/reward profile. When biotech M&A heats up, XBI often outperforms.
AUM$6.5B
Expense Ratio0.35%
Holdings145
Dividend Yield0.1%
DistributionQuarterly
BenchmarkS&P Biotechnology Select Industry Index
InceptionJan 2006
ExchangeNYSEARCA
Price Data
Open$134.91
Prev Close$133.79
Day Range$134.25 — $137.95
52W Range$66.66 — $132.09
52-Week Range
$66.66
$132.09
From 52W High
4.2%
From 52W Low
+106.5%
Investment Calculator
See how much dividend income XBI could generate based on its current price of $137.68 and 0.1% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,912.96
Annual Income$9.91
Monthly Income$0.83
Based on current dividend yield of 0.1%. Actual distributions may vary. Past dividends do not guarantee future payments.
Biotechnology ETF Comparison
Top Biotechnology Stocks
View all →
| Stock | Price | Change | Market Cap |
|---|---|---|---|
| ABBV | $201.55 | -0.57% | 372.29B |
| AMGN | $331.70 | +0.79% | 176.88B |
| GILD | $131.33 | -2.04% | 163.92B |
| VRTX | $429.82 | +1.13% | 109.50B |
| REGN | $714.89 | +0.82% | 74.30B |
| ALNY | $295.05 | -0.29% | 40.90B |
| RVMD | $141.81 | -0.49% | 30.30B |
| INSM | $101.35 | -3.48% | 29.13B |
| BIIB | $193.45 | +1.08% | 28.76B |
| NTRA | $194.24 | -11.64% | 27.65B |
XBI FAQ
What is XBI?
XBI is the SPDR S&P Biotech ETF, an exchange-traded fund managed by SPDR (State Street). It tracks the S&P Biotechnology Select Industry Index and holds 145 Biotechnology securities with an expense ratio of 0.35%.
What is the expense ratio of XBI?
XBI charges an annual expense ratio of 0.35%, which means you pay $35.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does XBI pay dividends?
Yes, XBI pays a 0.1% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $10.00 per year in dividend income.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
Last updated: May 6, 2026 at 10:15 PM ET